| | | | | | | |
 | VERTEX PHARMACEUTICALS INCORPORATED | -0.79% | -3.43% | 14.27% | 20.55% | 18.97% | 84 989 |
| REGENERON PHARMACEUTICALS, INC. | 0.01% | -4.48% | 0.49% | 4.66% | 25.40% | 77 660 |
 | WUXI APPTEC CO., LTD. | -2.65% | -3.48% | -18.49% | -28.61% | 8.02% | 27 488 |
 | GENMAB A/S | -0.11% | -0.07% | -4.11% | 33.59% | 36.03% | 26 444 |
| BEIGENE, LTD. | 4.03% | 1.85% | 7.71% | 76.84% | 45.91% | 24 766 |
 | ARGENX SE | 0.32% | -3.13% | 7.75% | 25.18% | 95.98% | 22 297 |
| SAREPTA THERAPEUTICS, INC. | -1.58% | -14.94% | -2.13% | 69.89% | -17.11% | 11 813 |
| LEGEND BIOTECH CORPORATION | -0.24% | -9.47% | 26.46% | 47.74% | --.--% | 10 766 |
| NEUROCRINE BIOSCIENCES, INC. | -1.04% | -3.02% | -23.63% | -2.02% | -24.12% | 8 901 |
| KARUNA THERAPEUTICS, INC. | 0.16% | -1.68% | 12.05% | 104.79% | 144.31% | 8 244 |
| EXELIXIS, INC. | 0.53% | -3.34% | 19.26% | 3.97% | -21.37% | 6 229 |
| INTRA-CELLULAR THERAPIES, INC. | 0.05% | -3.56% | 13.76% | 3.29% | 186.39% | 5 775 |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | 2.55% | 2.90% | 5.90% | 22.57% | --.--% | 5 238 |
| MADRIGAL PHARMACEUTICALS, INC. | 1.17% | 2.99% | -1.85% | 314.73% | 144.70% | 5 210 |
| ASCENDIS PHARMA A/S | 1.46% | -0.71% | -26.51% | 1.08% | -38.86% | 5 045 |
| | | | | | | |
| | Durchschnitt | 0.26% | -2.90% | 2.06% | 46.55% | 46.48% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | -0.10% | -3.31% | 3.73% | 26.20% | 32.74% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
